Literature DB >> 32168460

The long-lasting effects of the acute respiratory distress syndrome.

Matthew F Mart1, Lorraine B Ware1,2.   

Abstract

Introduction: Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury common in critically ill patients and characterized by significant morbidity and mortality. It frequently manifests long-lasting effects beyond hospitalization, from cognitive impairment to physical weakness.Areas covered: Several complications of ARDS have been identified in patients after hospital discharge. The authors conducted literature searches to identify observational studies, randomized clinical trials, systematic reviews, and guidelines. A summary of is presented here to outline the sequelae of ARDS and their risk factors with a focus on the limited but growing research into possible therapies. Long term sequelae of ARDS commonly identified in the literature include long-term cognitive impairment, psychological morbidities, neuromuscular weakness, pulmonary dysfunction, and ongoing healthcare utilization with reduced quality of life.Expert opinion: Given the public health significance of long-term complications following ARDS, the development of new therapies for prevention and treatment is of vital importance. Furthering knowledge of the pathophysiology of these impairments will provide a framework to develop new therapeutic targets to fuel future clinical trials in this area of critical care medicine.

Entities:  

Keywords:  acute respiratory distress syndrome; long-term outcomes

Mesh:

Year:  2020        PMID: 32168460      PMCID: PMC7454121          DOI: 10.1080/17476348.2020.1743182

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  87 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial.

Authors:  James C Jackson; Timothy D Girard; Sharon M Gordon; Jennifer L Thompson; Ayumi K Shintani; Jason W W Thomason; Brenda T Pun; Angelo E Canonico; Janet G Dunn; Gordon R Bernard; Robert S Dittus; E Wesley Ely
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

3.  Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study.

Authors:  Sean M Bagshaw; H Thomas Stelfox; Robert C McDermid; Darryl B Rolfson; Ross T Tsuyuki; Nadia Baig; Barbara Artiuch; Quazi Ibrahim; Daniel E Stollery; Ella Rokosh; Sumit R Majumdar
Journal:  CMAJ       Date:  2013-11-25       Impact factor: 8.262

4.  Health-related quality of life and return to work after critical illness in general intensive care unit patients: a 1-year follow-up study.

Authors:  Hilde Myhren; Øivind Ekeberg; Olav Stokland
Journal:  Crit Care Med       Date:  2010-07       Impact factor: 7.598

5.  The Incremental Burden of Acute Respiratory Distress Syndrome: Long-term Follow-up of a Population-Based Nested Case-Control Study.

Authors:  Michelle Biehl; Adil Ahmed; Rahul Kashyap; Amelia Barwise; Ognjen Gajic
Journal:  Mayo Clin Proc       Date:  2018-03-01       Impact factor: 7.616

6.  Cognitive decline after elective and nonelective hospitalizations in older adults.

Authors:  Bryan D James; Robert S Wilson; Ana W Capuano; Patricia A Boyle; Raj C Shah; Melissa Lamar; E Wesley Ely; David A Bennett; Julie A Schneider
Journal:  Neurology       Date:  2019-01-11       Impact factor: 9.910

Review 7.  ICU-Acquired Weakness.

Authors:  Sarah E Jolley; Aaron E Bunnell; Catherine L Hough
Journal:  Chest       Date:  2016-04-07       Impact factor: 9.410

Review 8.  What's Next After ARDS: Long-Term Outcomes.

Authors:  Davide Chiumello; Silvia Coppola; Sara Froio; Miriam Gotti
Journal:  Respir Care       Date:  2016-05       Impact factor: 2.258

Review 9.  Psychiatric morbidity in survivors of the acute respiratory distress syndrome: a systematic review.

Authors:  Dimitry S Davydow; Sanjay V Desai; Dale M Needham; O Joseph Bienvenu
Journal:  Psychosom Med       Date:  2008-04-23       Impact factor: 4.312

10.  Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome.

Authors:  Ramona O Hopkins; Lindell K Weaver; Dave Collingridge; R Bruce Parkinson; Karen J Chan; James F Orme
Journal:  Am J Respir Crit Care Med       Date:  2004-11-12       Impact factor: 21.405

View more
  11 in total

1.  Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.

Authors:  Zara Izadi; Milena A Gianfrancesco; Alfredo Aguirre; Anja Strangfeld; Elsa F Mateus; Kimme L Hyrich; Laure Gossec; Loreto Carmona; Saskia Lawson-Tovey; Lianne Kearsley-Fleet; Martin Schaefer; Andrea M Seet; Gabriela Schmajuk; Lindsay Jacobsohn; Patricia Katz; Stephanie Rush; Samar Al-Emadi; Jeffrey A Sparks; Tiffany Y-T Hsu; Naomi J Patel; Leanna Wise; Emily Gilbert; Alí Duarte-García; Maria O Valenzuela-Almada; Manuel F Ugarte-Gil; Sandra Lúcia Euzébio Ribeiro; Adriana de Oliveira Marinho; Lilian David de Azevedo Valadares; Daniela Di Giuseppe; Rebecca Hasseli; Jutta G Richter; Alexander Pfeil; Tim Schmeiser; Carolina A Isnardi; Alvaro A Reyes Torres; Gelsomina Alle; Verónica Saurit; Anna Zanetti; Greta Carrara; Julien Labreuche; Thomas Barnetche; Muriel Herasse; Samira Plassart; Maria José Santos; Ana Maria Rodrigues; Philip C Robinson; Pedro M Machado; Emily Sirotich; Jean W Liew; Jonathan S Hausmann; Paul Sufka; Rebecca Grainger; Suleman Bhana; Wendy Costello; Zachary S Wallace; Jinoos Yazdany
Journal:  ACR Open Rheumatol       Date:  2022-07-22

2.  Carbonic anhydrase IX proteoglycan-like and intracellular domains mediate pulmonary microvascular endothelial cell repair and angiogenesis.

Authors:  Reece P Stevens; Mikhail F Alexeyev; Natalia Kozhukhar; Viktoria Pastukh; Sunita S Paudel; Jessica Bell; Dhananjay T Tambe; Troy Stevens; Ji Young Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-06-07       Impact factor: 6.011

Review 3.  Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.

Authors:  Makhloufi Zoulikha; Qingqing Xiao; George Frimpong Boafo; Marwa A Sallam; Zhongjian Chen; Wei He
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 11.413

4.  Postexposure Liponucleotide Prophylaxis and Treatment Attenuates Acute Respiratory Distress Syndrome in Influenza-infected Mice.

Authors:  Lucia E Rosas; Lauren M Doolittle; Lisa M Joseph; Hasan El-Musa; Michael V Novotny; Judy M Hickman-Davis; R Duncan Hite; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2021-06       Impact factor: 6.914

5.  Mechanobiology of Pulmonary Diseases: A Review of Engineering Tools to Understand Lung Mechanotransduction.

Authors:  Caymen Novak; Megan N Ballinger; Samir Ghadiali
Journal:  J Biomech Eng       Date:  2021-11-01       Impact factor: 2.097

Review 6.  Quality of life following adult veno-venous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review.

Authors:  E R Kurniawati; V G H Rutjens; N P A Vranken; T S R Delnoij; R Lorusso; I C C van der Horst; J G Maessen; P W Weerwind
Journal:  Qual Life Res       Date:  2021-04-07       Impact factor: 4.147

7.  The Stanford Hall consensus statement for post-COVID-19 rehabilitation.

Authors:  Robert M Barker-Davies; Oliver O'Sullivan; Kahawalage Pumi Prathima Senaratne; Polly Baker; Mark Cranley; Shreshth Dharm-Datta; Henrietta Ellis; Duncan Goodall; Michael Gough; Sarah Lewis; Jonathan Norman; Theodora Papadopoulou; David Roscoe; Daniel Sherwood; Philippa Turner; Tammy Walker; Alan Mistlin; Rhodri Phillip; Alastair M Nicol; Alexander N Bennett; Sardar Bahadur
Journal:  Br J Sports Med       Date:  2020-05-31       Impact factor: 13.800

8.  Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in 'long COVID' patients with persistent dyspnoea.

Authors:  Isabelle Frésard; Léon Genecand; Marco Altarelli; Grégoire Gex; Petrut Vremaroiu; Andreea Vremaroiu-Coman; David Lawi; Pierre-Olivier Bridevaux
Journal:  BMJ Open Respir Res       Date:  2022-03

Review 9.  Advances in the use of exosomes for the treatment of ALI/ARDS.

Authors:  Chang Liu; Kun Xiao; Lixin Xie
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

10.  Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection.

Authors:  María C García-Hidalgo; Rafael Peláez; Jessica González; Sally Santisteve; Iván D Benítez; Marta Molinero; Manel Perez-Pons; Thalía Belmonte; Gerard Torres; Anna Moncusí-Moix; Clara Gort-Paniello; Maria Aguilà; Faty Seck; Paola Carmona; Jesús Caballero; Carme Barberà; Adrián Ceccato; Laia Fernández-Barat; Ricard Ferrer; Dario Garcia-Gasulla; Jose Ángel Lorente-Balanza; Rosario Menéndez; Ana Motos; Oscar Peñuelas; Jordi Riera; Jesús F Bermejo-Martin; Antoni Torres; Ferran Barbé; David de Gonzalo-Calvo; Ignacio M Larráyoz
Journal:  Biomed Pharmacother       Date:  2022-08-30       Impact factor: 7.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.